查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年亞太地區上游生物加工市場預測 - 區域分析 - 按產品類型、工作流程、使用類型和模式
市場調查報告書
商品編碼
1567861

2030 年亞太地區上游生物加工市場預測 - 區域分析 - 按產品類型、工作流程、使用類型和模式

Asia Pacific Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type, Workflow, Usage Type, and Mode
出版日期: | 出版商: The Insight Partners | 英文 130 Pages | 訂單完成後即時交付

價格

2022年亞太上游生物加工市場價值為19.761億美元，預計2030年將達到56.7899億美元；預計2022年至2030年複合年成長率為14.1%。

技術進步推動亞太地區上游生物加工市場。

上游生物加工市場正經歷一波技術進步浪潮，帶來了巨大的產業機會。這些進步包括細胞培養系統、生物反應器設計、製程監測和控制以及自動化和數位化整合的創新發展。 2023 年 9 月，Repligen 公司和 Sartorius 推出了整合生物反應器系統。 Repligen 的 XCell 交替切向流 (ATF) 上游強化技術已整合到 Sartorius Biostat 攪拌釜反應器 (STR) 中。此生物反應器技術旨在使生物製藥公司更容易應用氮氣灌注和強化種子培養。 Biostat STR 中整合了嵌入式 XCell ATF 硬體和軟體模組，該模組將整合製程分析技術與預先定義的高階控制配方相結合。該模組旨在簡化細胞生長的管理並增強灌注過程中的細胞保留，從而無需單獨的細胞保留控制塔。此類現代產品具有增強的製程效率、可擴展性和適應性，這對於滿足生物製藥生產不斷變化的需求至關重要。

先進的細胞培養基配方和下一代生物反應器技術有助於上游生物加工的最佳化，進而實現更高的產品產量、改善的產品品質以及複雜生物製劑的高效生產。進階分析和即時過程監控的持續整合正在徹底改變生物加工中數據驅動的決策，推動精度和製程最佳化機會。生物技術的進步也促進了靈活和模組化製造平台的發展。此外，機器學習、人工智慧和預測分析的融合正在為預測性生物加工鋪平道路，從而釋放主動製程控制、品質保證和成本最佳化的機會。因此，上游生物加工的技術進步正在重塑該產業，為創新、效率和適應性提供了新的途徑。

亞太地區上游生物加工市場概況

亞太地區上游生物加工市場分為中國、日本、澳洲、印度、韓國和亞太地區其他地區。預計該地區市場在 2022 年至 2030 年期間將以最高複合年成長率成長。中國、印度和日本是亞太地區市場成長的三個主要貢獻者，這主要是由生物反應器需求的成長以及研究中心和政府資助的增加所推動的。此外，許多國際市場參與者將重點放在亞太地區國家，以實現地理擴張和其他策略。

亞太地區上游生物加工市場營收及 2030 年預測（百萬美元）

亞太地區上游生物加工市場區隔

亞太地區上游生物加工市場根據產品類型、工作流程、使用類型、模式和國家進行細分。根據產品類型，亞太地區上游生物加工市場分為生物反應器/發酵槽、細胞培養、過濾器、袋子和容器等。 2022 年，生物反應器/發酵槽服務佔據最大的市場佔有率。

根據工作流程，亞太上游生物加工市場分為培養基製備、細胞培養和細胞分離。 2022 年，細胞分離佔據最大的市場佔有率。

根據使用類型，亞太地區上游生物加工市場分為一次性和多用途。到 2022 年，一次性產品將佔據更大的市場佔有率。

根據模式，亞太上游生物加工市場分為內部和外包。 2022 年，In-house 佔據了更大的市場佔有率。

依國家/地區分類，亞太地區上游生物加工市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022年，中國將主導亞太地區上游生物加工市場佔有率。

Thermo Fisher Scientific Inc、Esco Micro Pte Ltd、Sartorius AG、Danaher Corp、Getinge AB、Merck KGaA、Corning Inc 和 Entegris Inc 是亞太上游生物加工市場的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：亞太地區上游生物加工市場格局

  • 概述
  • PEST分析

第 5 章：亞太地區上游生物加工市場 - 主要市場動態

  • 市場促進因素
    • 一次性生物反應器的商業用途
    • 生物製藥製造外包
    • 醫藥和生技產業快速成長
  • 市場限制
    • 嚴格的規範架構
  • 市場機會
    • 技術進步
  • 未來趨勢
    • 加大生醫產業研發投入
  • 促進因素和限制的影響：

第 6 章：上游生物加工市場 - 亞太地區分析

第 7 章：亞太地區上游生物加工市場分析 - 按產品類型

  • 生物反應器/發酵罐
  • 細胞培養
  • 過濾器
  • 袋子和容器
  • 其他

第 8 章：亞太地區上游生物加工市場分析 - 按工作流程

  • 媒體準備
  • 細胞培養
  • 細胞分離

第 9 章：亞太地區上游生物加工市場分析 - 按使用類型

  • 一次使用
  • 多用途

第 10 章：亞太地區上游生物加工市場分析 - 按模式

  • 內部
  • 外包

第 11 章：亞太地區上游生物加工市場 - 國家分析

  • 亞太市場概況
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 亞太地區其他地區

第 12 章：產業格局

  • 概述
  • 上游生物加工市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Thermo Fisher Scientific Inc
  • Esco Micro Pte Ltd
  • Sartorius AG
  • Danaher Corp
  • Getinge AB
  • Merck KGaA
  • Corning Inc
  • Entegris Inc

第 14 章：附錄

Product Code: BMIRE00030685

The Asia Pacific upstream bioprocessing market was valued at US$ 1,976.10 million in 2022 and is expected to reach US$ 5,678.99 million by 2030; it is estimated to grow at a CAGR of 14.1% from 2022 to 2030.

Technological Advancements Boost Asia Pacific Upstream Bioprocessing Market.

The upstream bioprocessing market is experiencing a wave of technological advancements, presenting considerable industry opportunities. These advancements include innovative developments in cell culture systems, bioreactor design, process monitoring, and control, as well as the integration of automation and digitalization. In September 2023, Repligen Corporation and Sartorius introduced an integrated bioreactor system. Repligen's XCell Alternating Tangential Flow (ATF) upstream intensification technology has been integrated into the Sartorius Biostat stirred-tank reactor (STR). This bioreactor technology is designed to make the application of N perfusion and intensified seed train easier for biopharmaceutical firms. An embedded XCell ATF hardware and software module that combines integrated process analytical technologies with predefined advanced control recipes is incorporated into Biostat STR. This module is intended to simplify the management of cell growth and enhance cell retention in perfusion procedures, eliminating the need for a separate cell retention control tower. Such modern products feature enhanced process efficiency, scalability, and adaptability, which are crucial for meeting the evolving demands of biopharmaceutical production.

Advanced cell culture media formulations and next-generation bioreactor technologies are contributing to the optimization of upstream bioprocessing, in turn, enabling higher product yields, improved product quality, and the efficient production of complex biologics. The ongoing integration of advanced analytics and real-time process monitoring is revolutionizing data-driven decision-making in bioprocessing, driving precision and process optimization opportunities. Progress in biotechnology also fosters the development of flexible and modular manufacturing platforms. Additionally, the convergence of machine learning, artificial intelligence, and predictive analytics is paving the way for predictive bioprocessing, thereby unlocking proactive process control, quality assurance, and cost optimization opportunities. Thus, technological advancements in upstream bioprocessing are reshaping the industry, presenting new avenues for innovation, efficiency, and adaptability.

Asia Pacific Upstream Bioprocessing Market Overview

The Asia Pacific upstream bioprocessing market is segmented into China, Japan, Australia, India, South Korea, and the Rest of Asia Pacific. The market in this region is expected to grow at the highest CAGR during 2022-2030. China, India, and Japan are three major contributors to the growth of the market in Asia Pacific, which is mainly driven by rising demand for bioreactors as well as an increase in research centers and government funding. Moreover, many international market players are focusing on countries in Asia Pacific for geographic expansion and other strategies.

Asia Pacific Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Upstream Bioprocessing Market Segmentation

The Asia Pacific upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country. Based on product type, the Asia Pacific upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022.

Based on workflow, the Asia Pacific upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022.

Based on usage type, the Asia Pacific upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022.

Based on mode, the Asia Pacific upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022.

Based on country, the Asia Pacific upstream bioprocessing market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific upstream bioprocessing market share in 2022.

Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Sartorius AG, Danaher Corp, Getinge AB, Merck KGaA, Corning Inc, and Entegris Inc are some of the leading companies operating in the Asia Pacific upstream bioprocessing market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Upstream Bioprocessing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Asia Pacific Upstream Bioprocessing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Commercial Use of Single-Use Bioreactors
    • 5.1.2 Outsourcing of Biopharmaceutical Manufacturing
    • 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Framework
  • 5.3 Market Opportunities
    • 5.3.1 Technological Advancements
  • 5.4 Future Trends
    • 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry
  • 5.5 Impact of Drivers and Restraints:

6. Upstream Bioprocessing Market - Asia Pacific Analysis

7. Asia Pacific Upstream Bioprocessing Market Analysis - by Product Type

  • 7.1 Bioreactors/Fermenters
    • 7.1.1 Overview
    • 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Cell Culture
    • 7.2.1 Overview
    • 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Filters
    • 7.3.1 Overview
    • 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Bags and Containers
    • 7.4.1 Overview
    • 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Upstream Bioprocessing Market Analysis - by Workflow

  • 8.1 Media Preparation
    • 8.1.1 Overview
    • 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Cell Culture
    • 8.2.1 Overview
    • 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Cell Separation
    • 8.3.1 Overview
    • 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Upstream Bioprocessing Market Analysis - by Usage Type

  • 9.1 Single-use
    • 9.1.1 Overview
    • 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Multi-use
    • 9.2.1 Overview
    • 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Upstream Bioprocessing Market Analysis - by Mode

  • 10.1 In-house
    • 10.1.1 Overview
    • 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Outsourced
    • 10.2.1 Overview
    • 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Upstream Bioprocessing Market - Country Analysis

  • 11.1 Asia Pacific Market Overview
    • 11.1.1 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.2 China
      • 11.1.1.3 China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 China: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.3.2 China: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.3.3 China: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.3.4 China: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.4 Japan
      • 11.1.1.5 Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Japan: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.5.2 Japan: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.5.3 Japan: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.5.4 Japan: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.6 India
      • 11.1.1.7 India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.7.1 India: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.7.2 India: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.7.3 India: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.7.4 India: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.8 Australia
      • 11.1.1.9 Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.9.1 Australia: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.9.2 Australia: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.9.3 Australia: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.9.4 Australia: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.10 South Korea
      • 11.1.1.11 South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.11.1 South Korea: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.11.2 South Korea: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.11.3 South Korea: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.11.4 South Korea: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.12 Rest of Asia Pacific
      • 11.1.1.13 Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.13.1 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.13.2 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.13.3 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.13.4 Rest of Asia Pacific: Upstream Bioprocessing Market Breakdown, by Mode

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Upstream Bioprocessing Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Esco Micro Pte Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Sartorius AG
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Danaher Corp
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Getinge AB
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Merck KGaA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Entegris Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Upstream Bioprocessing Market Segmentation
  • Table 2. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 3. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 4. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 5. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 6. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Country
  • Table 7. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 8. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 9. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 10. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 11. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 12. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 13. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 14. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 15. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 16. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 17. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 18. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 19. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 20. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 21. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 22. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 23. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 24. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 25. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 26. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 27. Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 28. Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 29. Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 30. Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 31. Recent Organic Growth Strategies in Upstream Bioprocessing Market
  • Table 32. Recent Inorganic Growth Strategies in the Upstream Bioprocessing Market
  • Table 33. Glossary of Terms, Upstream Bioprocessing Market

List Of Figures

  • Figure 1. Upstream Bioprocessing Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Upstream Bioprocessing Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Upstream Bioprocessing Market Revenue (US$ Million), 2020-2030
  • Figure 6. Upstream Bioprocessing Market Share (%) - by Product Type (2022 and 2030)
  • Figure 7. Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Upstream Bioprocessing Market Share (%) - by Workflow (2022 and 2030)
  • Figure 13. Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Upstream Bioprocessing Market Share (%) - by Usage Type (2022 and 2030)
  • Figure 17. Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Upstream Bioprocessing Market Share (%) - by Mode (2022 and 2030)
  • Figure 20. In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. Asia Pacific: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 24. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Rest of Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Growth Strategies in Upstream Bioprocessing Market